Skip to main content

Change location

You are currently on the Global (English) website

My country is not on the list

Global

  • Bracco.com (English)

Asia

  • China (中文)
  • Japan (日本語)
  • South Korea (한국어)

Americas

  • Brazil (Português)
  • Canada (English)
  • Mexico (Español)
  • Canada (Français)
  • USA (English)

Europe

  • Austria (English)
  • Belgium (English)
  • Czech Republic (English)
  • Denmark (English)
  • Finland (English)
  • France (Français)
  • Germany (Deutsch)
  • Iceland (English)
  • Italy (Italiano)
  • Luxembourg (English)
  • Norway (English)
  • Poland (English)
  • Slovakia (English)
  • Sweden (English)
  • Switzerland (English)
  • The Netherlands (English)
  • UK (English)
  • Global (English)
  • Careers
  • Media and News
  • Get in touch
    • Global (English)
    • We are Bracco
    • Our businesses
    • Purpose and values
    • Our history
    • Our Foundation
    • Responsibility and Ethical conduct
    • Product overview
    • X-ray/CT
    • MRI
    • CEUS
    • Molecular Imaging
    • Cardiovascular
    • Digital Health
    • Oncology
    • Cardiology
    • Digital future
    • R&D
    • The Bracco sites
    • Scientific heritage and patents
      • Cell Therapy
      • Cell Therapy Overview
      • Products
      • Resources
    • Education
    • Next-Gen Projects
    • Bracco Global Academy
    • Our Partnerships
    • Sustainability
    • Sustainability report
    • Key International conferences
    • Global Educational events
  • Our Stories
  1. Home
  2. Cell Therapy

Cells

BubbleGen CD3+ Cell Selection Kit

Microbubble-based isolation of CD3+ T cells for cell therapy research.

 

BubbleGen™ CD3+ Cell Selection Kit, RUO

BubbleGen™ CD3+ Cell Selection Kit, RUO

 

The BubbleGen™ CD3+ Cell Selection Kit provides a ready-to-use solution for enrichment of CD3+ T cells using Bracco's BubbleGen™ microbubble technology. 

 

List price per kit: $850 USD

 

 

Request a quote 

 

Contact Support

Chart BubbleGen Performance

Target Cell Population: CD3+ T Cells 

Technology: Antibody-conjugated microbubbles 

Input Capacity: Up to 1 billion total cells 

Workflow Type: Positive selection 

 

CD3+ T Cell Isolation Performance 

BubbleGen™ microbubbles demonstrated comparable or superior CD3+ T cell isolation to benchmark magnetic bead-based methods using peripheral blood mononuclear (PBMC) samples across key metrics including cell recovery, purity, and viability.

  • 2X vials BubbleGen™ Streptavidin Microbubbles
  • 1X vials BubbleGen™ Human CD3 Biotin Positive Selection Antibody
  • 2X vial adapters 

 

To simplify your cell selection research workflow, compatible Cell Separators are available for purchase here.

Scientific Posters

 

View All Resources

BubbleGen™ products are supplied through Bracco's commercial ordering process. 

 

After submitting your quote request, a member of our team will contact you to confirm your product requirements, pricing, and shipping information. 

 

By placing an order, you agree to Bracco's Terms and Conditions of Sale.

FAQs

  • What are lipid-based microbubbles, and how do they work?

    Our microbubbles are tiny, lipid-based structures designed to selectively bind and isolate target cells. They leverage surface chemistry to attach to specific markers, enabling efficient cell selection and activation without the need for beads or columns.

     

    How do microbubbles differ from traditional bead-based or column-based methods?

    Unlike bead or column systems, microbubbles provide a gentle, bead-free, and column-free approach. This reduces mechanical stress on cells, simplifies research workflows, and eliminates the need for magnetic or filtration equipment.

     

    What makes your technology gentle compared to other cell separation techniques?

    Microbubbles minimize shear forces and avoid harsh physical constraints, preserving cell integrity and viability. This is critical for sensitive cell types used in cell therapy research.

  • How are microbubbles used in cell therapy research workflows?

    They can be integrated into steps such as cell selection, activation, and enrichment. Their flexibility allows seamless incorporation into existing research processes.

     

    Can microbubbles be applied to both cell selection and activation?

    Yes. Our technology supports dual functionality—enabling precise selection of target cells and activation signals when needed.

     

    Are microbubbles compatible with different cell types or therapies?

    Yes, they are designed for versatility and can be adapted to select for T cells, NK cells, HSC cells, and other immune cell populations and subpopulations commonly used in cell therapy research.

     

     

  • What are the advantages of bead-free and column-free cell selection?

    This approach reduces process complexity, eliminates costly consumables, and avoids residual selection beads in the final research product. This can reduce the analytical burden associated with demonstrating removal of selection reagents and streamline research workflows.

     

    How does your technology improve consistency and performance in cell processing?

    Microbubbles deliver reproducible results, ensuring high yield, purity and viability.

     

    Does using microbubbles reduce processing time or complexity?

    Yes. By removing steps associated with magnetic separation or filtration, microbubbles streamline research workflows and shorten processing times.

 

 

Let’s Discuss Your Research Workflow.

 

Every cell therapy research process is different. Partner with our team to identify how BubbleGen™ can help address your cell selection challenges and support your research program goals.

 

Contact Our Team

For Research Use Only. Not for Use in Humans.

Please login to DocCheck
to view our products

Register here Forgot your password?

The Bracco Group is an international group of highly specialized companies.
We are an active part of the healthcare sector, and a global leader in diagnostic imaging.

  • We are Bracco
  • Our Portfolio
  • Innovation
  • Education
  • Events
  • Sustainability
  • Our Stories
  • Pharmacovigilance
  • Data Protection

Connect with us

Via Egidio Folli 50
20134 Milan, Italy
Phone + 39 02 2177.1

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • Imprint
  • for Bracco VPN users

Bracco Copyright © 2026 | Registered office: Via E. Folli, 50, 20134 Milano, Italy | Share Capital € 104.000.000 f.p. | VAT Milan Comp. Reg. n. 00825120157 | Milan REA n. 348182